STOCK TITAN

Joanne Crevoiserat sells 81,000 shares for TPR (NYSE: TPR)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Joanne C. Crevoiserat reported a sale of 81,000 common shares on 11/21/2025 for $8,530,304.40.

The filing also lists planned cash sales of common shares tied to options: 35,770 shares from options granted 08/19/2019 and 30,292 shares from options granted 08/17/2020, each dated 02/18/2026.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What did the Form 144 for TPR report?

The Form 144 reports a sale of 81,000 common shares by Joanne C. Crevoiserat on 11/21/2025 for $8,530,304.40. It also lists planned cash sales tied to options dated 02/18/2026.

How many shares were sold by Joanne C. Crevoiserat and for how much?

Joanne C. Crevoiserat sold 81,000 common shares on 11/21/2025 for a total of $8,530,304.40, as disclosed in the Form 144 excerpt provided.

Is the Form 144 an indication of issuer share issuance or insider resale?

This Form 144 records an insider resale: a reported sale of 81,000 shares by Joanne C. Crevoiserat and lists planned cash sales tied to option exercises; it does not state issuer issuance or proceeds to the company.